Metapro 3D 50 Tablet is a combination antihypertensive medication containing Chlorthalidone 12.5 mg, Metoprolol Succinate 50 mg, and Telmisartan 40 mg. This formulation is designed to provide comprehensive blood pressure control by targeting multiple physiological pathways. Chlorthalidone, a thiazide-like diuretic, promotes sodium and water excretion, reducing plasma volume and peripheral resistance. Metoprolol Succinate, a selective beta-1 adrenergic receptor blocker, decreases heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure and reducing cardiac workload. Telmisartan, an angiotensin II receptor blocker (ARB), inhibits the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to vasodilation and decreased blood pressure. The synergistic action of these agents effectively manages hypertension, reduces the risk of cardiovascular events, and improves patient compliance by combining three antihypertensive mechanisms in a single tablet. Metapro 3D 50 is indicated for the treatment of essential hypertension, especially in patients requiring multiple drug therapy for adequate blood pressure control. It should be used under medical supervision, with monitoring of blood pressure, renal function, and electrolyte levels to minimize potential adverse effects such as hypotension, electrolyte imbalance, bradycardia, or renal impairment.